Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update for the CONQUER study, which investigates cessation of nicotine using e-cigarette reduction. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VapeAway | Conditions: Addiction Nicotine | Phase 2 | Status: RECRUITING